Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc. (KVUE) Investors and Encourages Investors to Contact the Firm Before December 8, 2023
Investors have until December 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- Investors have until December 8, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
- On November 12, 2021, Johnson & Johnson announced the creation of Kenvue as a wholly owned consumer health subsidiary.
- On May 3, 2022, Johnson & Johnson and Kenvue jointly announced that the price of Kenvue’s IPO would be $22 per share.
- Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation.